We are live on
!
Find out more
DA
Dunvegan Associates Portfolio holdings
AUM
$85.1M
1-Year Est. Return
2.3%
This Fund
S&P 500
This Quarter
Est. Return
+3.98%
1 Year Est. Return
-2.3%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$119M
AUM Growth
-$2.39M
(-2%)
Cap. Flow
-$3.06M
Cap. Flow
% of AUM
-2.58%
Top 10 Holdings %
Top 10 Hldgs %
49.96%
Holding
224
New
153
Increased
5
Reduced
49
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$6.01M |
| 2 |
Cheniere Energy
LNG
|
+$918K |
| 3 |
Visa
V
|
+$252K |
| 4 |
CBI
Chicago Bridge & Iron Nv
CBI
|
+$172K |
| 5 |
Apple
AAPL
|
+$149K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$3.83M |
| 2 |
SPDR Gold Trust
GLD
|
+$1.84M |
| 3 |
NVO
Novo Nordisk
NVO
|
+$1.27M |
| 4 |
GEB.CL
General Electric Capital Corp
GEB.CL
|
+$1.05M |
| 5 |
SCHW.PRB.CL
The Charles Schwab Corporation
SCHW.PRB.CL
|
+$755K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 20.26% |
| 2 | Financials | 13.68% |
| 3 | Healthcare | 11.87% |
| 4 | Consumer Staples | 10.96% |
| 5 | Materials | 6.69% |
Similar funds
TSBJ
VCAM
KCA
TP
SPC
ST
CGC
GCG
Dunvegan Associates's Q1 2014 Portfolio in Review
As of Q1 2014, Dunvegan Associates held 224 positions worth $119M, down 2% from $121M the previous quarter. Its ten largest holdings account for 50% of the portfolio.
Dunvegan Associates's Q1 2014 filing shows 153 new, 5 increased, 49 reduced and 8 closed positions. Its largest new stake was Allergan plc: 30,358 shares worth $3.77M. The largest sale was Allergan Inc, an estimated $3.83M.
By sector, the portfolio is most concentrated in Energy at 20% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.
- Dunvegan Associates's largest Q1 2014 buy was Allergan plc: 30,358 shares worth $3.77M.
- Dunvegan Associates added most to Cheniere Energy in Q1 2014, an estimated $918K increase.
- Dunvegan Associates's biggest Q1 2014 reduction was SPDR Gold Trust, cutting an estimated $1.84M.
- Dunvegan Associates fully exited Allergan Inc in Q1 2014, selling an estimated $3.83M.
- Dunvegan Associates's ten largest holdings make up 50% of its $119M portfolio in Q1 2014.
- Dunvegan Associates opened 153 new positions and closed 8 in Q1 2014.
- Dunvegan Associates's portfolio value fell 2% quarter-over-quarter to $119M.
Based on Dunvegan Associates's 13F filing for Q1 2014, filed 28 Apr 2017.